PUBLISHER: The Business Research Company | PRODUCT CODE: 1829224
PUBLISHER: The Business Research Company | PRODUCT CODE: 1829224
Diabetes care devices are employed to monitor and manage blood glucose levels in individuals with diabetes.
The primary categories of diabetes care devices include blood glucose test strips, insulin pens, syringes, pumps and injectors, lancing devices and equipment, continuous glucose monitoring devices and equipment, and blood glucose meters. Insulin pens are devices equipped with a needle to administer insulin into the subcutaneous tissue. Expenditures can be classified as public or private, and the products utilized fall into the categories of instruments/equipment and disposables. Testing methods encompass both point-of-care (POC) testing and non-point-of-care (POC) testing, with diverse end-users, including hospitals and clinics, diagnostic laboratories, and others.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.
The diabetes care devices market research report is one of a series of new reports from The Business Research Company that provides diabetes care devices market statistics, including diabetes care devices industry global market size, regional shares, competitors with a diabetes care devices market share, detailed diabetes care devices market segments, market trends and opportunities, and any further data you may need to thrive in the diabetes care devices industry. This diabetes care devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The diabetes care devices market size has grown rapidly in recent years. It will grow from $66.46 billion in 2024 to $73.91 billion in 2025 at a compound annual growth rate (CAGR) of 11.2%. The growth in the historic period can be attributed to increasing diabetes prevalence, economic growth, public health insurance reforms, increased geriatric population, and increased healthcare expenditure.
The diabetes care devices market size is expected to see rapid growth in the next few years. It will grow to $115.94 billion in 2029 at a compound annual growth rate (CAGR) of 11.9%. The growth in the forecast period can be attributed to increase in R&D investments and research collaborations, increase in disease burden, government initiatives and technological development. Major trends in the forecast period include stick free glucose testing, glucose responsive insulins (GRIS), artificial pancreas, shift in traditional insulin syringes, wearable and mobile glucose monitoring systems, intelligent glucose meters.
The forecast of 11.9% growth over the next five years indicates a slight reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on continuous glucose monitoring sensors and insulin pump microprocessors, sourced from key regions such as Ireland and Singapore, which could lead to reduced diabetes management options and higher out-of-pocket expenses for patients.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
Rising healthcare expenditures are expected to drive the growth of the diabetes care device market in the future. Healthcare expenditures refer to the total amount spent on healthcare services, products, and activities over a specific period, typically measured at the individual, community, national, or global level. The combination of increasing healthcare expenditures, improved access to healthcare services, and a rise in diabetes diagnoses contributes to higher investments in research and development. This, in turn, leads to advancements in diabetes care devices, including enhanced glucose monitoring systems, insulin delivery devices, and digital health solutions. For example, in November 2023, Eurostat, a government agency based in Europe, reported that in 2022, social protection spending on sickness and healthcare in the EU reached 8.1% of GDP. Among the 24 EU countries with available data, France had the highest expenditure at 10.0%, followed by Germany at 9.7%, while Bulgaria had the lowest at 4.2%. Other countries with lower spending included Ireland (4.6%), Hungary and Lithuania (4.7%), and Estonia (4.8%). Therefore, the increase in healthcare expenditure is poised to fuel the growth of the diabetes care device market in the coming years.
Changing consumer preferences and busy lifestyles are contributing to shifts in the disease profile of the global population, particularly in the realm of non-communicable diseases such as diabetes. Factors such as extended working hours, limited physical activity, and unhealthy dietary and drinking habits play a significant role in the prevalence of diabetes. According to the International Diabetes Federation's IDF Diabetes Atlas 10th edition in July 2021, the estimated global population living with diabetes is projected to rise to 643 million by 2030 and further increase to 783 million by 2045. This marks an increase from approximately 537 million adults aged 20 to 79 living with diabetes in 2021. These factors are anticipated to contribute to the growth of the market in the forecast period.
Leading companies in the diabetes care devices market are concentrating on creating innovative products, such as the Medtronic Extended Infusion, to boost profitability. The Medtronic Extended Infusion Set is a tubing device that transports insulin from the pump to the body and is designed for use over a period of up to seven days. For example, in November 2022, Medtronic, a US-based medical device firm, introduced the Medtronic Extended Infusion Set. This infusion set employs advanced materials to reduce insulin preservative loss and improve flow, effectively extending the set's wear time to double. Its innovative design features a new tubing connector and a robust adhesive patch, ensuring insulin stability and comfort for up to seven days.
In the pursuit of innovative advancements, pharmaceutical companies are actively investing in the development and commercialization of glucose-responsive insulins (GRIs), presenting significant opportunities for the evolution of novel insulin delivery devices. Notably, Novo Nordisk, a Danish pharmaceutical company, has committed an investment of $800 million to acquire the UK biotech start-up Ziylo for the development of GRIs. Simultaneously, companies such as Eli Lily and Sanofi have initiated research projects aimed at the development of GRIs. These smart insulins automatically activate or deactivate in response to fluctuating glucose levels in the blood, enhancing the effectiveness of diabetes treatment and reducing the occurrence of hyperglycemia and hypoglycemia.
Major companies operating in the diabetes care devices market include Becton Dickinson and Company, Roche Holding AG, Nipro Corporation, HTL-STREFA Inc., ARKRAY, Terumo Corporation, Owen Mumford, Ypsomed AG, Vogt Medical, Sanofi India, Biocon Ltd, Mehar healthcare, Johnson & Johnson, Shandong WeiGao Group Medical Polymer Company Limited, Yuwell medical equipment & supply Co, Medtronic, Emperra GmbH E-Health, Novo Nordisk A/S, Insujet, Eli Lilly, Fresenius Medical Care, Siemens, Stryker, Teleflex Medical, LifeScan, Ascensia Diabetes Care, Tandem Diabetes Care, Dexcom Inc., SocialDiabetes, Dottli, Themis Bioscience, Ok biotech, Acon Laboratories, Bayer AG, AgaMatrix.
North America was the largest region in the global diabetes care devices market in 2024. Western Europe was the second largest region in the global diabetes care devices market. The regions covered in the diabetes care devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the diabetes care devices market report are Australia, China, India, Indonesia, Japan, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, France, Germany, UK, Austria, Belgium, Denmark, Finland, Ireland, Italy, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa
The diabetes care devices market consists of sales of blood glucose monitoring devices, insulin delivery devices, smart insulin pens and others that are used for monitor and treat diabetes patient. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Diabetes Care Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on diabetes care devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for diabetes care devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The diabetes care devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.